| Literature DB >> 34122550 |
Mehdi Khemiss1,2,3, Ines Kallel3,4,5, Hela Zouaghi1,3,4, Mohamed Ben Khelifa1,2,3, Sana Bagga3,6,7.
Abstract
OBJECTIVE: The aim of this clinical study was to evaluate the effectiveness of a whitening toothpaste containing 3% carbamide peroxide and lactoperoxidase. Materials and methods. Participants were instructed to brush their teeth using an enzymatic-activated dentifrice following a particular procedure for three weeks. Color was recorded before and after treatment using a VITA Easyshade spectrophotometer. Differences in L ∗ (tooth color lightness), a ∗ (displacement along the red-green axis), and b ∗ (displacement along the yellow-blue axis) were measured before and after treatment using the paired t and the Wilcoxon signed-rank tests. Color changes (Δ E ) were calculated using the obtained measurements.Entities:
Year: 2021 PMID: 34122550 PMCID: PMC8172322 DOI: 10.1155/2021/7143623
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
Figure 1pH 700 meter.
Figure 2The VITA Easyshade Advance 4.0 spectrophotometer.
Figure 3The customized positioning ring.
Figure 4Flowchart of participants included in the study.
Characteristics of the treatment group (n = 19) and the control group (n = 19).
| Treatment | Control |
| ||
|---|---|---|---|---|
| Data in mean ± standard deviation | ||||
| Age | 26.2 ± 4.2 | 26.2 ± 4.2 | — | |
| Data in number (percentage) | ||||
| Gender | Male | 6 (32) | 6 (32) | — |
| Female | 13 (68) | 13 (68) | ||
|
| ||||
| Socioeconomic level | Low | 0 (0) | 0 (0) | — |
| High | 19 (100) | 19 (100) | ||
|
| ||||
| Tooth brushing | <2 | 6 (32) | 2 (11) | 0.23 |
| ≥2 | 13 (68) | 17 (89) | ||
|
| ||||
| Tobacco use | Yes | 3 (16) | 0 (0) | 0.23 |
| No | 16 (84) | 19 (100) | ||
|
| ||||
| Coloring drinks | Yes | 14 (74) | 18 (95) | 0.18 |
| No | 5 (26) | 1 (5) | ||
|
| ||||
| Bleaching treatment | Yes | 3 (16) | 1 (5) | 0.60 |
| No | 16 (84) | 18 (95) | ||
Plaque index, gingival index, and potential hydrogen of the treatment group (n = 19) and the control group (n = 19).
| Treatment | Control |
| |
|---|---|---|---|
| Data in mean ± standard deviation | |||
| PIbaseline value | 0.56 ± 0.45 | 0.37 ± 0.34 | 0.16 |
| ΔPI | −0.24 ± 0.47 | −0.25 ± 0.25 | 0.14 |
| GIbaseline value | 0.45 ± 0.31 | 0.17 ± 0.19 | 0.01 |
| ΔGI | −0.25 ± 0.30 | −0.13 ± 0.13 | 0.13 |
| pHbaseline value | 6.83 ± 0.35 | 6.87 ± 0.4 | 0.77 |
| ΔpH | 0.04 ± 0.51 | 0.18 ± 0.3 | 0.40 |
p < 0.05 (t-test): treatment group vs. controls.
L , a, b, and ΔE values for the treatment group (n = 19) and the control group (n = 19).
| Treatment | Control |
| |
|---|---|---|---|
| Data in mean ± standard deviation | |||
| ΔL | 0.16 ± 3.64 | −1.62 ± 3.34 | 0.20 |
| Δa | −0.90 ± 0.40 | −0.12 ± 0.31 | 0.81 |
| Δb | 0.02 ± 2.22 | −0.43 ± 0.95 | 0.48 |
| ΔE | 5.34 ± 2.31 | 4.32 ± 1.56 | 0.16 |
L , a, b, and ΔE values for each tooth of the treatment group (n = 19) and the control group (n = 19).
| Treatment | Control |
| ||
|---|---|---|---|---|
| Data in mean ± standard deviation | ||||
| 11 | Δ | −0.88 ± 4.94 | −1.47 ± 4.43 | 0.74 |
| Δ | −0.26 ± 0.89 | −0.03 ± 0.38 | 0.23 | |
| Δ | −1.02 ± 3.20 | 0.69 ± 2.80 | 0.09 | |
| Δ | 4.59 ± 3.91 | 4.61 ± 2.81 | 0.98 | |
|
| ||||
| 12 | Δ | −0.89 ± 6.15 | −1.84 ± 4.17 | 0.62 |
| Δ | 0.01 ± 0.88 | −0.02 ± 0.54 | 0.90 | |
| Δ | 0.45 ± 5.12 | −0.12 ± 1.97 | 0.67 | |
| Δ | 6.46 ± 4.67 | 4.27 ± 2.42 | 0.04 | |
|
| ||||
| 13 | Δ | 0.09 ± 5.31 | −2.67 ± 3.61 | 0.11 |
| Δ | −0.1[−0.4; 0.1] | 0.1[−0.2; 0.3] | 0.37 | |
| Δ | 0.38 ± 4.00 | −0.74 ± 2.46 | 0.35 | |
| Δ | 5.24 ± 4.04 | 4.59 ± 2.27 | 0.58 | |
|
| ||||
| 21 | Δ | −0.89 ± 7.29 | −1.39 ± 3.36 | 0.82 |
| Δ | 0.10 ± 1.04 | 0.18 ± 0.47 | 0.71 | |
| Δ | −0.38 ± 3.22 | 1.12 ± 3.27 | 0.18 | |
| Δ | 5.1[2.9; 8.4] | 4.8[2.8; 5.5] | 0.24 | |
|
| ||||
| 22 | Δ | 0.53 ± 5.04 | −1.26 ± 3.27 | 0.28 |
| Δ | 0.12 ± 4.47 | 0.15 ± 0.57 | 0.86 | |
| Δ | 0.48 ± 3.63 | 0.74 ± 2.61 | 0.80 | |
| Δ | 5.06 ± 3.52 | 3.65 ± 2.45 | 0.22 | |
|
| ||||
| 23 | Δ | −0.60 ± 6.25 | −1.71 ± 2.77 | 0.50 |
| Δ | 0.11 ± 0.63 | −0.01 ± 0.56 | 0.58 | |
| Δ | 0.18 ± 2.56 | −0.47 ± 1.61 | 0.30 | |
| Δ | 5.44 ± 3.90 | 3.24 ± 1.67 | 0.06 | |
|
| ||||
| 31 | Δ | 0.50 ± 4.58 | −2.55 ± 4.45 | 0.10 |
| Δ | −0.44 ± 0.82 | −0.26 ± 0.52 | 0.45 | |
| Δ | −0.29 ± 3.62 | −0.97 ± 2.16 | 0.53 | |
| Δ | 5.10 ± 2.81 | 4.71 ± 3.05 | 0.65 | |
|
| ||||
| 32 | Δ | 1.29 ± 5.27 | −1.41 ± 3.95 | 0.13 |
| Δ | −0.21 ± 0.97 | −0.26 ± 0.85 | 0.88 | |
| Δ | 0.57 ± 3.72 | −0.52 ± 1.60 | 0.27 | |
| Δ | 5.71 ± 3.21 | 4.01 ± 2.10 | 0.11 | |
|
| ||||
| 33 | Δ | 0.91 ± 6.30 | −0.52 ± 3.89 | 0.46 |
| Δ | 0.22 ± 0.76 | 0.10 ± 0.52 | 0.63 | |
| Δ | 0.98 ± 5.04 | −0.30 ± 2.00 | 0.35 | |
| Δ | 6.38 ± 4.97 | 3.78 ± 2.18 | 0.06 | |
|
| ||||
| 41 | Δ | 1.25 ± 4.59 | −2.08 ± 4.81 | 0.07 |
| Δ | −0.29 ± 0.83 | 0.01 ± 0.55 | 0.24 | |
| Δ | −0.05 ± 2.60 | 0.07 ± 1.91 | 0.89 | |
| Δ | 4.79 ± 2.47 | 4.65 ± 2.96 | 0.89 | |
|
| ||||
| 42 | Δ | 0.61 ± 4.67 | −1.01 ± 5.29 | 0.41 |
| Δ | −0.45 ± 0.73 | −0.44 ± 0.7 | 0.95 | |
| Δ | −0.95 ± 2.33 | −0.50 ± 2.02 | 0.51 | |
| Δ | 4.64 ± 2.59 | 4.83 ± 3.07 | 0.83 | |
|
| ||||
| 43 | Δ | 0.03 ± 4.04 | −1.52 ± 5.87 | 0.34 |
| Δ | −0.13 ± 0.50 | −0.15 ± 0.62 | 0.89 | |
| Δ | 0.1[−1.9; 1.4] | −0.1[−1.5; 1.2] | 0.71 | |
| Δ | 4.17 ± 1.89 | 5.06 ± 4.07 | 0.38 | |
aData are median (first quartile-third quartile).p < 0.05 (t-test): treatment group vs. controls.
ΔE values for each shade of the treatment group and the control group (n = 19).
| Treatment | Control |
| |
|---|---|---|---|
| Data in median (first quartile-third quartile) | |||
| A1 | 4.39 [2.36–5.76] | 3.60 [2.03–5.48] | 0.209 |
| A2 | 3.97 [2.89–5.09] | 3.18 [1.77–5.17] | 0.206 |
| A3 | 4.69 [2.43–8.10] | 5.15 [4.27–7.28] | 0.425 |
| A3.5 | 4.08 [3.33–7.06] | 2.36 [1.74–4.08] | 0.004 |
| A4 | 7.28 [2.98–10.57] | 8.08 [4.75–11.97] | 0.705 |
| B1 | 5.12 [2.31–12.99] | 4.82 [3.70–9.23] | 0.741 |
| B2 | 3.95 [2.28–6.53] | 3.31 [1.80–6.44] | 0.529 |
| B3 | 4.30 [2.86–7.86] | 3.71 [2.57–5.96] | 0.206 |
p < 0.05 (test of Mann–Whitney): treatment vs. controls.